Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyang-Mi Lee

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Biomolecules & Therapeutics|March 10, 2022
Strategies for Manipulating T Cells in Cancer ImmunotherapyHyang-Mi Lee
Biomolecules & Therapeutics|June 6, 2024
Engineered T Cell Receptor for Cancer ImmunotherapySo Won Lee, Hyang-Mi Lee
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Rare development of Foxp3+ thymocytes in the CD4+CD8+ subsetHyang Mi Lee, Chyi-Song Hsieh
Journal of Microbiology and Biotechnology|June 21, 2019
Synthetic Bacteria for TherapeuticsPhuong Vo, Hyang-Mi Lee, Dokyun Na
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|February 24, 2022
The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open stateHyang Mi Lee, Sang June Hahn, Bok Hee Choi
Biological & Pharmaceutical Bulletin|June 5, 2010
Inhibitory action of fluvoxamine on Kv1.5 currentsHyang Mi Lee, Sang June Hahn, Bok Hee Choi
Advances in Immunology|November 29, 2011
Thymic and peripheral differentiation of regulatory T cellsHyang-Mi Lee, Jhoanne Lynne Bautista, Chyi-Song Hsieh
Biomedicines|September 23, 2022
Inflammatory Cytokine: An Attractive Target for Cancer TreatmentHyang-Mi Lee, Hye-Jin Lee, Ji-Eun Chang
Biochemical and Biophysical Research Communications|May 26, 2026
Leveraging CRISPR/Cas9 for optimized adoptive T cell therapies: From molecular engineering to clinical manufacturingJi-Hyeon Kim, Hyo Jung Cho, Hyang-Mi Lee
FEBS Letters|October 9, 2016
Glutathione upregulates cAMP signalling via G protein alpha 2 during the development of Dictyostelium discoideumHyang-Mi Lee, Ji-Sun Kim, Sa-Ouk Kang
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Biomolecules & Therapeutics|March 10, 2022
Strategies for Manipulating T Cells in Cancer ImmunotherapyHyang-Mi Lee
Biomolecules & Therapeutics|June 6, 2024
Engineered T Cell Receptor for Cancer ImmunotherapySo Won Lee, Hyang-Mi Lee
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Rare development of Foxp3+ thymocytes in the CD4+CD8+ subsetHyang Mi Lee, Chyi-Song Hsieh
Journal of Microbiology and Biotechnology|June 21, 2019
Synthetic Bacteria for TherapeuticsPhuong Vo, Hyang-Mi Lee, Dokyun Na
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|February 24, 2022
The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open stateHyang Mi Lee, Sang June Hahn, Bok Hee Choi
Biological & Pharmaceutical Bulletin|June 5, 2010
Inhibitory action of fluvoxamine on Kv1.5 currentsHyang Mi Lee, Sang June Hahn, Bok Hee Choi
Advances in Immunology|November 29, 2011
Thymic and peripheral differentiation of regulatory T cellsHyang-Mi Lee, Jhoanne Lynne Bautista, Chyi-Song Hsieh
Biomedicines|September 23, 2022
Inflammatory Cytokine: An Attractive Target for Cancer TreatmentHyang-Mi Lee, Hye-Jin Lee, Ji-Eun Chang
Biochemical and Biophysical Research Communications|May 26, 2026
Leveraging CRISPR/Cas9 for optimized adoptive T cell therapies: From molecular engineering to clinical manufacturingJi-Hyeon Kim, Hyo Jung Cho, Hyang-Mi Lee
FEBS Letters|October 9, 2016
Glutathione upregulates cAMP signalling via G protein alpha 2 during the development of Dictyostelium discoideumHyang-Mi Lee, Ji-Sun Kim, Sa-Ouk Kang
Pageof 6